Item 9 Labs Stock Last Dividend Paid
| INLB Stock | USD 0.0001 0.00 0.00% |
Item 9 Labs fundamentals help investors to digest information that contributes to Item 9's financial success or failures. It also enables traders to predict the movement of Item Pink Sheet. The fundamental analysis module provides a way to measure Item 9's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Item 9 pink sheet.
Item |
Item 9 Labs Company Last Dividend Paid Analysis
Item 9's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Item 9 Labs has a Last Dividend Paid of 0.0. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Item Fundamentals
| Return On Equity | -0.42 | |||
| Return On Asset | -0.0721 | |||
| Profit Margin | (1.43) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | 52.06 M | |||
| Shares Outstanding | 100 M | |||
| Shares Owned By Insiders | 25.71 % | |||
| Price To Book | 0.28 X | |||
| Price To Sales | 0.95 X | |||
| Revenue | 21.76 M | |||
| Gross Profit | 7.31 M | |||
| EBITDA | (22.83 M) | |||
| Net Income | (31.14 M) | |||
| Cash And Equivalents | 441.66 K | |||
| Total Debt | 7.22 M | |||
| Debt To Equity | 0.39 % | |||
| Current Ratio | 0.14 X | |||
| Book Value Per Share | 0.64 X | |||
| Cash Flow From Operations | (2.25 M) | |||
| Earnings Per Share | (0.18) X | |||
| Target Price | 4.0 | |||
| Number Of Employees | 97 | |||
| Beta | 0.77 | |||
| Market Capitalization | 17.25 M | |||
| Total Asset | 110.76 M | |||
| Z Score | 1.2 | |||
| Net Asset | 110.76 M |
About Item 9 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Item 9 Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Item 9 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Item 9 Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Item Pink Sheet
Item 9 financial ratios help investors to determine whether Item Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Item with respect to the benefits of owning Item 9 security.